Because IDH1/2 mutations maintain through tumor recurrence [24], the secondary tumor with IDH1/2 wild-type was no recurrence from the primary tumor with IDH2 mutation but was a de novo tumor that was most likely to be related to the previous exposure. This evidence concerns the gene IDH2 and neoplasm.